Immuneering Corp - Class A common stock, par value $0.001 per share (IMRX)

CUSIP: 45254E107

Q2 2023 13F Holders as of 30 Jun 2023

Type / Class
Equity / Class A common stock, par value $0.001 per share
Shares outstanding
66,027,379
Total 13F shares
17,269,962
Share change
+5,446,404
Total reported value
$175,881,466
Price per share
$10.14
Number of holders
49
Value change
+$55,986,602
Number of buys
39
Number of sells
12

Quarterly Holders Quick Answers

What is CUSIP 45254E107?
CUSIP 45254E107 identifies IMRX - Immuneering Corp - Class A common stock, par value $0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Immuneering Corp - Class A common stock, par value $0.001 per share (IMRX) as of Q2 2023

As of 30 Jun 2023, Immuneering Corp - Class A common stock, par value $0.001 per share (IMRX) was held by 49 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 17,269,962 shares. The largest 10 holders included Cormorant Asset Management, LP, PRICE T ROWE ASSOCIATES INC /MD/, BlackRock Inc., CITADEL ADVISORS LLC, VANGUARD GROUP INC, BANK OF MONTREAL /CAN/, FMR LLC, GOLDMAN SACHS GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, and STATE STREET CORP. This page lists 49 institutional shareholders reporting positions in this security for the Q2 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.